Brean Murray Carret & Co. Starts Edwards Lifesciences (EW) at Hold; Pole Position Makes EW a Good Story, but Valuation Limited Rate of Price Appreciation

Article Stock Quotes (1) Comments (0)

Brean Murray Carret & Co. initiates coverage on Edwards Lifesciences (NYSE: EW) with a Hold.

Brean analyst says, "EW Lifesciences has the lead technology and market position in aortic transcatheter heart values, arguably the most exciting opportunity in Med Tech today."

For more ratings news on Edwards Lifesciences click here and for the rating history of Edwards Lifesciences click here.

Shares of Edwards Lifesciences closed at $85.58 yesterday, with a 52 week range of $51.35-$91.82.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• East West Adopts Advance Notice Policy
• Topeka Capital Starts InvenSense (INVN) at Buy
• Topeka Capital Starts Diodes (DIOD) at Buy

Create E-mail Alert Related Categories

New Coverage

Related Entities

Brean Murray Carret & Co.

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?